Educational Opportunities

This course includes: 

• Video presentation by a leading expert
• Pre- and post-exams to measure your understanding
• CME and MOC claiming online

Kevin Yuen, MD, FRCP, FACE 

Kevin C.J. Yuen, MD, FRCP (UK), FACE is a Professor of Medicine and Medical Director of the Barrow Neuroendocrinology Clinic in the Department of Neuroendocrinology at Barrow Neurological Institute, University of Arizona College of Medicine and Creighton School of Medicine. He is board certified in Internal Medicine and Endocrinology, Diabetes and Metabolism by the American Board of Internal Medicine. Dr. Yuen focuses his clinical practice on the diagnosis and treatment of pituitary and adrenal disorders, with a particular interest in growth hormone deficiency and excess, hypogonadism, and cortisol deficiency and excess. Dr. Yuen has conducted many growth hormone dosing and diagnostic studies, and long-acting growth hormone formulation studies in adults with growth hormone deficiency. Dr Yuen has published extensively, authored several book chapters, and is a frequent guest speaker on various topics related to pituitary disorders. He also serves on several medical committees, namely the Pituitary Scientific Committee for the American Association of Clinical Endocrinologists, and is the Chair of the Task Force for the 2019 American Association of Clinical Endocrinologists Writing Committee for “Medical guidelines for clinical practice for growth hormone use in growth hormone deficient adults and transition patients”. He is a on the Editorial Board for Endocrine Practice and is the Editor-in-Chief for Growth Hormone and IGF Research journal, and is an ad hoc reviewer for many other scientific journals. 

LEARNING OBJECTIVES

Upon completion of this activity, learners will be able to:

• Summarize the current knowledge about the accuracy of available GH–stimulation tests, safety of GH replacement, and dispelling the myth of using GH for sports and aging.
• Propose a framework for pediatric and adult endocrinologists to manage patients with GHD effectively during transition to adult care and adulthood.
• Discuss new developments in the field, particularly the status of long-acting GH preparations.

MAINTENANCE OF CERTIFICATION

Successful completion of this CME activity enables the participant to earn up to 1 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points. 

Your participation information will be shared with the ACCME, which will in turn report your points to ABIM. Successful completion of a course examination is required to earn ABIM MOC points.

ACCREDITATION AND DESIGNATION STATEMENTS

The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.